Please try another search
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Sharon Curran | 56 | 2018 | Independent Non-Executive Director |
Jonathan Emms | 61 | 2019 | COO & Executive Director |
Ian Roy Johnson | 71 | 2019 | Executive Chairman |
Nicholas Harwood Bertram Mills | 34 | 2020 | Non-Independent Non-Executive Director |
Garry Watts | 68 | 2020 | Senior Independent Director |
Joanna Susan Le Couilliard | 61 | 2018 | Independent Non-Executive Director |
Michael Roy David Roller | 59 | 2020 | CFO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review